skip to Main Content

Quality Improvement

Quality improvement is central to achieving high-value care. Learn how we collaborate with all industry stakeholders to identify and bridge measurement gaps and advance patient care.

FDA and Sponsors Discuss Quality Challenges in the Breakthrough Therapy Pathway

Need to Know: On June 10, Friends of Cancer Research held a public meeting to discuss how sponsors and FDA may be able to expedite rate-limiting steps in Chemistry, Manufacturing, and Controls (CMC) and current Good Manufacturing Practices (cGMPs) for breakthrough therapy designated products, while ensuring an adequate supply of safe and efficacious product at the time of approval.

Nelly Ganesen

Avalere Health Releases Enhanced Recovery White Paper

"On June 10, 2014, the Center for Medical Technology Policy (CMTP) in collaboration with Avalere Health hosted a multi-stakeholder forum in Baltimore, Maryland, to discuss potential challenges and opportunities to accelerate the adoption of enhanced recovery protocols (ERPs) in the U.S.

Podcast: Quality Measurement Is the Foundation for Improving Quality Care

The use of quality and performance measures in public reporting, value-based purchasing, and alternative payment models is altering clinical practice by providing incentives to improve quality measures performance and provide high-value care. Debbie Lucas helps many stakeholders seek to understand these measures, assess their business impacts, and use the information to guide decision-making.

Back To Top